-
Solriamfetol, sold
under the
brand name Sunosi, is a wakefulness-promoting
medication used in the
treatment of
excessive sleepiness related to narcolepsy...
-
medications include alerting agents (e.g., modafinil, armodafinil, pitolisant,
solriamfetol),
oxybate medications (e.g.,
twice nightly sodium oxybate,
twice nightly...
- (Meretran)
Prolintane (Promotil, Katovit)
Pyrovalerone (Centroton, Thymergix)
Solriamfetol (Sunosi)
Tametraline (CP-24,411) WY-46824 Some NDRIs, such as methylphenidate...
- and well-balanced norepinephrine–dopamine
reuptake inhibitor (NDRI)
solriamfetol (brand name Sunosi; O-carbamoyl-D-phenylalaninol) is a
derivative of...
- of
solriamfetol at human, mouse, and rat TAAR1 receptors. hTAAR1 EC50
values (10–16 μM) were
within the
clinically observed therapeutic solriamfetol plasma...
-
improved tolerability and
lower abuse potential (eg, modafinil/armodafinil,
solriamfetol, pitolisant) "Adderall XR
Prescribing Information" (PDF).
United States...
-
atypical DRIs with
known or
potential wakefulness-promoting
effects include solriamfetol (also a
norepinephrine reuptake inhibitor), vanoxerine, phenylpiracetam...
- is
another common side
effect and may
require additional treatment.
Solriamfetol is a
dopamine and
norepinephrine reuptake inhibitor (NDRI) used to treat...
- (January 7, 2020). "Schedules of
Controlled Substances:
Placement of
Solriamfetol in
Schedule IV".
Federal Register. Drug
Enforcement Administration. Retrieved...
-
Propylamphetamine Pseudoephedrine Ropinirole Salbutamol (Levosalbutamol)
Sibutramine Solriamfetol Synephrine Theodrenaline Tiflorex Tranylcypromine Tyramine Tyrosine Xylopropamine...
